相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
Ali Rostami et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis
Wan Yang et al.
LANCET INFECTIOUS DISEASES (2021)
Drivers of Infectious Disease Seasonality: Potential Implications for COVID-19
N. Kronfeld-Schor et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2021)
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
S. F. Lumley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
Lewis F. Buss et al.
SCIENCE (2021)
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
Anna Jeffery-Smith et al.
EUROSURVEILLANCE (2021)
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Ester C. Sabino et al.
LANCET (2021)
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Jun Wu et al.
NATURE COMMUNICATIONS (2021)
Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
Pyoeng Gyun Choe et al.
EMERGING INFECTIOUS DISEASES (2021)
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
Stuart P. Weisberg et al.
NATURE IMMUNOLOGY (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings
Tuo Ji et al.
CLINICAL INFECTIOUS DISEASES (2020)
SARS-CoV-2 antibody testing-questions to be asked
Mustafa K. Oezcueruemez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Abishek Chandrashekar et al.
SCIENCE (2020)
The important role of serology for COVID-19 control
Amy K. Winter et al.
LANCET INFECTIOUS DISEASES (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
Elena Percivalle et al.
EUROSURVEILLANCE (2020)
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
Bastian Fischer et al.
EUROSURVEILLANCE (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Masks Do More Than Protect Others During COVID-19: Reducing the Inoculum of SARS-CoV-2 to Protect the Wearer
Monica Gandhi et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Silvia Stringhini et al.
LANCET (2020)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollan et al.
LANCET (2020)
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K. Chu et al.
LANCET (2020)
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
Adam J. Kucharski et al.
LANCET INFECTIOUS DISEASES (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques
Wei Deng et al.
SCIENCE (2020)
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
Corine H. GeurtsvanKessel et al.
NATURE COMMUNICATIONS (2020)
Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Seasonal coronavirus protective immunity is short-lasting
Arthur W. D. Edridge et al.
NATURE MEDICINE (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
Emelie Marklund et al.
PLOS ONE (2020)
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Ellen Shrock et al.
SCIENCE (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Ann-Sofie Rudberg et al.
NATURE COMMUNICATIONS (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
Katharina Roltgen et al.
SCIENCE IMMUNOLOGY (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
Ed Slot et al.
NATURE COMMUNICATIONS (2020)
Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer et al.
NATURE (2020)
Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells
Monica Bodogai et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Pregnancy and Infection
Athena P. Kourtis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
B cells and aging: molecules and mechanisms
Michael P. Cancro et al.
TRENDS IN IMMUNOLOGY (2009)
Duration of antibody responses after severe acute respiratory syndrome
Li-Ping Wu et al.
EMERGING INFECTIOUS DISEASES (2007)
Emerging infections and pregnancy
Denise J. Jamieson et al.
EMERGING INFECTIOUS DISEASES (2006)
Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63
KH Chan et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2005)